A5039525018- HIV/AIDS Research and Interventions
- Mobile Health and mHealth Applications
- Medication Adherence and Compliance
- Privacy, Security, and Data Protection
- HIV Research and Treatment
- HIV/AIDS drug development and treatment
- Bipolar Disorder and Treatment
- HIV, Drug Use, Sexual Risk
- FinTech, Crowdfunding, Digital Finance
- Digital Mental Health Interventions
Abstract Background QUANTI-TAF aimed to establish tenofovir-diphosphate (TFV-DP)/emtricitabine-triphosphate (FTC-TP) adherence benchmarks in dried blood spots (DBS) for persons with human immunodeficiency virus (PWH) receiving tenofovir alafenamide/emtricitabine (TAF/FTC)–based antiretroviral therapy (ART). Methods For 16 weeks, PWH received TAF/FTC-based ART co-encapsulated an ingestible sensor directly measure cumulative (enrollment final visit) and 10-day adherence. At monthly visits,...
Background Digital pill systems (DPSs), which comprise ingestible radiofrequency sensors integrated into a gelatin capsule that overencapsulates medication, can directly measure ingestion events. Objective Teaching users to operate DPS is vital ensure the collection of actionable and adherence data. In this study, we aim develop pilot training program, grounded in Technology Acceptance Model, instruct individuals on operation. Methods A two-part comprising in-person text message–based...
Once-daily oral pre-exposure prophylaxis (PrEP) is highly effective for HIV prevention, but its efficacy dependent on adherence, which can be challenging men who have sex with (MSM) substance use. Digital pill systems (DPS) represent a novel tool directly measuring adherence through ingestible radiofrequency sensors that confirm ingestions in real-time. We examined operational challenges across two studies involving DPS to measure PrEP adherence. While most participants successfully operated...
Adherence to medications is a complex task that requires biobehavioral support. To better provide tools assist with medication adherence, digital pills an option directly measure taking behaviors. These systems comprise gelatin capsule radiofrequency emitter, wearable Reader collects the radio signal and smartphone app ingestion data displays it for patients clinicians. are feasible in measuring adherence real-world, even stigmatized diseases like HIV treatment adherence. While current...
<sec> <title>BACKGROUND</title> Digital pill systems (DPSs), which comprise ingestible radiofrequency sensors integrated into a gelatin capsule that overencapsulates medication, can directly measure ingestion events. </sec> <title>OBJECTIVE</title> Teaching users to operate DPS is vital ensure the collection of actionable and adherence data. In this study, we aim develop pilot training program, grounded in Technology Acceptance Model, instruct individuals on operation. <title>METHODS</title>...